ESC 365 - Real-world early effectiveness and safety of inclisiran in China Pilot Zone: An interim analysis of 3-month data from a prospective non-interventional cohort study

EAPC Premium Access

Real-world early effectiveness and safety of inclisiran in China Pilot Zone: An interim analysis of 3-month data from a prospective non-interventional cohort study

Session: Late-Breaking Science session

Topic: Lipid-Lowering Agents

Speaker: Ms Y. Qiao (CN)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Ms Yongping Qiao

(China)

1 presentation

2 followers

4 more presentations in this session

The real-world cost and health resource utilization associated to the CNIC-polypill containing Atorvastatin 20mg in secondary prevention patients: a subanalysis of the NEPTUNO study

Speaker: Doctor A. Cordero (Elche, ES)

Prolonged moderate-intensity exercise does not increase muscle injury markers in symptomatic or asymptomatic statin users

Speaker: Mrs N. Allard (Nijmegen, NL)

Flemish study on environment, genes and health outcomes

Speaker: Doctor N. Cauwenberghs (Leuven, BE)

Prevalence of new-onset diabetes mellitus, associated factors and outcomes of hyperglycemia on mortality among hospitalized COVID-19 patients

Speaker: Doctor F. Kalokola (Mwanza, TZ)

Access the full session

Late-Breaking Science session

Speakers: Ms Y. Qiao, Doctor A. Cordero, Mrs N. Allard, Doctor N. Cauwenberghs, Doctor F. Kalokola

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources